Emily Ricotta
- Epidemiology top 5%
- Infectious Diseases top 5%
- Molecular Medicine top 1%
- Applied Microbiology and Biotechnology top 0.5%
- Public Health, Environmental and Occupational Health top 5%
- Co-authors
- D. Rebecca PrevotsJennifer AdjemianSameer S. KadriYi Ling LaiHannah KoenkerChanu RheeJohn P. DekkerMichael Klompas
- Topics
- Mycobacterium research and diagnosis (9 papers)Antibiotic Use and Resistance (7 papers)Mosquito-borne diseases and control (7 papers)
- Partner nations
- United StatesUnited KingdomTanzania
In The Last Decade
Emily Ricotta
41 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Epidemiology 496
- Infectious Diseases 468
- Molecular Medicine 411
- Applied Microbiology and Biotechnology 341
- Public Health, Environmental and Occupational Health 331
Countries citing papers authored by Emily Ricotta
This map shows the geographic impact of Emily Ricotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Ricotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Ricotta more than expected).
Fields of papers citing papers by Emily Ricotta
This network shows the impact of papers produced by Emily Ricotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Ricotta. The network helps show where Emily Ricotta may publish in the future.
Co-authorship network of co-authors of Emily Ricotta
This figure shows the co-authorship network connecting the top 25 collaborators of Emily Ricotta. A scholar is included among the top collaborators of Emily Ricotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Ricotta. Emily Ricotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 9 | |
| 6 | 25 | |
| 7 | 5 | |
| 8 | 75 | |
| 9 | 5 | |
| 10 | 162 | |
| 11 | 42 | |
| 12 | 19 | |
| 13 | 69 | |
| 14 | 8 | |
| 15 | 1 | |
| 16 | 40 | |
| 17 | 4 | |
| 18 | Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agentsbreakdown → | 377 |
| 19 | 35 | |
| 20 | 16 |
About Emily Ricotta
Emily Ricotta is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Infectious Diseases, having authored 43 papers that have together received 1.5k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (9 papers), Antibiotic Use and Resistance (7 papers) and Mosquito-borne diseases and control (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (341 citations), Molecular Medicine (411 citations) and Clinical Biochemistry (189 citations). Emily Ricotta has collaborated with scholars based in United States, United Kingdom and Tanzania. Frequent co-authors include D. Rebecca Prevots, Jennifer Adjemian, Sameer S. Kadri, Yi Ling Lai, Hannah Koenker, Chanu Rhee, John P. Dekker, Michael Klompas, John H. Powers and Robert L. Danner. Their work appears in journals such as Nature Medicine, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.